Abstract
Brk (PTK6) is a nonreceptor protein tyrosine kinase, which is expressed in over 60% of breast carcinoma tissue samples and breast tumour cell lines, but not normal mammary tissue or benign lesions. Since experimental Brk expression in nontransformed mammary epithelial cells enhances their mitogenic response to epidermal growth factor, it was important to determine the role Brk plays in the proliferation of breast carcinoma cells and validate it as a therapeutic target. We have used RNA interference to efficiently and specifically downregulate Brk protein levels in breast carcinoma cells, and determined that this results in a significant suppression of their proliferation. Additionally, through the expression of a kinase-inactive mutant, we have determined that Brk can mediate promotion of proliferation via a kinase-independent mechanism, potentially functioning as an ‘adapter’. These data identify Brk as a novel target for antiproliferative therapy in the majority of breast cancers, and illustrate the power of RNA interference for rapidly validating candidate therapeutic targets.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barker KT, Jackson LE and Crompton MR . (1997). Oncogene, 15, 799–805.
Caplen NJ, Parrish S, Imani F, Fire A and Morgan RA . (2001). Proc. Natl. Acad. Sci. USA, 98, 9742–9747.
Derry JJ, Richard S, Valderrama Carvajal H, Ye X, Vasioukhin V, Cochrane AW, Chen T and Tyner AL . (2000). Mol. Cell. Biol., 20, 6114–6126.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T . (2001). Nature, 411, 494–498.
Fry MJ . (2001). Breast Cancer Res., 3, 304–312.
Gasco M, Shami S and Crook T . (2002). Breast Cancer Res., 4, 70–76.
Hayes DF and Thor AD . (2002). Semin. Oncol., 29, 231–245.
Hutvagner G and Zamore PD . (2002). Curr. Opin. Genet. Dev., 12, 225–232.
Kamalati T, Jolin HE, Fry MJ and Crompton MR . (2000). Oncogene, 19, 5471–5476.
Kamalati T, Jolin HE, Mitchell PJ, Barker KT, Jackson LE, Dean CJ, Page MJ, Gusterson BA and Crompton MR . (1996). J. Biol. Chem., 271, 30956–30963.
Kim H and Muller WJ . (1999). Exp. Cell Res., 253, 78–87.
Lee H, Kim M, Lee KH, Kang KN and Lee ST . (1998). Mol. Cells, 8, 401–407.
Llor X, Serfas MS, Bie W, Vasioukhin V, Polonskaia M, Derry J, Abbott CM and Tyner AL . (1999). Clin. Cancer Res., 5, 1767–1777.
Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Lowe PN, Page MJ, Gusterson BA and Crompton MR . (1994). Oncogene, 9, 2383–2390.
Mitchell PJ, Sara EA and Crompton MR . (2000). Oncogene, 19, 4273–4282.
Olayioye MA, Neve RM, Lane HA and Hynes NE . (2000). EMBOJ., 19, 3159–3167.
Qui H and Miller WT . (2002). J. Biol. Chem., 277, 34634–34641.
Tuschl T . (2002). Nat. Biotechnol., 20, 446–448.
Vasioukhin V, Serfas MS, Siyanova EY, Polonskaia M, Costigan VJ, Liu B, Thomason A and Tyner AL . (1995). Oncogene, 10, 349–357.
Vasioukhin V and Tyner AL . (1997). Proc. Natl. Acad. Sci. USA, 94, 14477–14482.
Zeng Y, Wagner EJ and Cullen BR . (2002). Mol Cell, 9, 1327–1333.
Acknowledgements
We thank Dr Michael Fry, University of Reading, for helpful comments. AJH was supported by a grant from the Association for International Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harvey, A., Crompton, M. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene 22, 5006–5010 (2003). https://doi.org/10.1038/sj.onc.1206577
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206577
Keywords
This article is cited by
-
Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma
Journal of Translational Medicine (2013)
-
Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models
Oncogenesis (2013)
-
Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR
Oncogene (2012)
-
Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo
Oncogenesis (2012)
-
Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance
Tumor Biology (2011)